Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance.

Gunton JE, Cheung NW, Hitchman R, Hams G, O'Sullivan C, Foster-Powell K, McElduff A.

Diabetes Care. 2005 Mar;28(3):712-3. No abstract available.

PMID:
15735214
3.

Dietary chromium tripicolinate supplementation reduces glucose concentrations and improves glucose tolerance in normal-weight cats.

Appleton DJ, Rand JS, Sunvold GD, Priest J.

J Feline Med Surg. 2002 Mar;4(1):13-25.

PMID:
11869052
4.

Glucose and insulin responses to dietary chromium supplements: a meta-analysis.

Althuis MD, Jordan NE, Ludington EA, Wittes JT.

Am J Clin Nutr. 2002 Jul;76(1):148-55.

5.

Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients.

Vanschoonbeek K, Thomassen BJ, Senden JM, Wodzig WK, van Loon LJ.

J Nutr. 2006 Apr;136(4):977-80.

6.

Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels.

Uusitupa MI, Mykkänen L, Siitonen O, Laakso M, Sarlund H, Kolehmainen P, Räsänen T, Kumpulainen J, Pyörälä K.

Br J Nutr. 1992 Jul;68(1):209-16.

PMID:
1390605
7.
8.
9.

Effect of chromium supplementation on glucose tolerance and lipid profile.

Bahijri SM.

Saudi Med J. 2000 Jan;21(1):45-50.

PMID:
11533750
10.

Chromium and polyphenols from cinnamon improve insulin sensitivity.

Anderson RA.

Proc Nutr Soc. 2008 Feb;67(1):48-53. doi: 10.1017/S0029665108006010.

PMID:
18234131
11.

Effects of acute chromium supplementation on postprandial metabolism in healthy young men.

Frauchiger MT, Wenk C, Colombani PC.

J Am Coll Nutr. 2004 Aug;23(4):351-7.

PMID:
15310739
12.

Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance.

Garcia AL, Otto B, Reich SC, Weickert MO, Steiniger J, Machowetz A, Rudovich NN, Möhlig M, Katz N, Speth M, Meuser F, Doerfer J, Zunft HJ, Pfeiffer AH, Koebnick C.

Eur J Clin Nutr. 2007 Mar;61(3):334-41. Epub 2006 Sep 20.

PMID:
16988651
13.

Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics.

Uusitupa MI, Kumpulainen JT, Voutilainen E, Hersio K, Sarlund H, Pyörälä KP, Koivistoinen PE, Lehto JT.

Am J Clin Nutr. 1983 Sep;38(3):404-10.

PMID:
6351586
15.

A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.

Marbury TC, Schwartz S, Rosenberg MA, Jariwala N, Becker RH, Johnston PS.

Exp Clin Endocrinol Diabetes. 2008 May;116(5):282-8. doi: 10.1055/s-2007-1022521.

PMID:
18484560
16.

Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance.

Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, Nakamura N, Kitawaki J, Imai S, Nakano K, Ohta M, Adachi T, Obayashi H, Yoshikawa T.

Nutr Res. 2008 Mar;28(3):137-43. doi: 10.1016/j.nutres.2008.01.008.

PMID:
19083400
17.

Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial.

Monti LD, Setola E, Lucotti PC, Marrocco-Trischitta MM, Comola M, Galluccio E, Poggi A, Mammì S, Catapano AL, Comi G, Chiesa R, Bosi E, Piatti PM.

Diabetes Obes Metab. 2012 Oct;14(10):893-900. doi: 10.1111/j.1463-1326.2012.01615.x. Epub 2012 May 21.

PMID:
22553931
18.

Chromium supplementation of human subjects: effects on glucose, insulin, and lipid variables.

Anderson RA, Polansky MM, Bryden NA, Roginski EE, Mertz W, Glinsmann W.

Metabolism. 1983 Sep;32(9):894-9.

PMID:
6350814
20.

Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance.

Derosa G, Cicero AF, D'Angelo A, Ragonesi PD, Ciccarelli L, Fogari E, Salvadeo SA, Ferrari I, Gravina A, Fassi R, Fogari R.

Clin Drug Investig. 2006;26(9):529-39.

PMID:
17163286

Supplemental Content

Support Center